ACHV logo

Achieve Life Sciences (ACHV) Operating Expenses

Annual Operating Expenses

$27.25 M
-$13.55 M-33.21%

31 December 2023

ACHV Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Operating Expenses

$12.47 M
+$4.04 M+47.86%

30 September 2024

ACHV Quarterly Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ACHV Operating Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-33.2%+89.7%
3 y3 years+84.8%+86.3%
5 y5 years+112.7%+235.4%

ACHV Operating Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-33.2%+84.8%-1.4%+184.2%
5 y5 years-33.2%+112.7%-1.4%+327.2%
alltimeall time-58.2%+1489.8%-39.1%+169.2%

Achieve Life Sciences Operating Expenses History

DateAnnualQuarterly
Sept 2024
-
$12.47 M(+47.9%)
June 2024
-
$8.43 M(+40.9%)
Mar 2024
-
$5.98 M(+36.4%)
Dec 2023
$27.25 M(-33.2%)
$4.39 M(-33.3%)
Sept 2023
-
$6.57 M(-14.8%)
June 2023
-
$7.71 M(-10.1%)
Mar 2023
-
$8.58 M(-21.0%)
Dec 2022
$40.80 M(+23.3%)
$10.86 M(-14.1%)
Sept 2022
-
$12.64 M(+25.5%)
June 2022
-
$10.07 M(+39.4%)
Mar 2022
-
$7.23 M(+1.6%)
Dec 2021
$33.09 M(+124.4%)
$7.12 M(+6.3%)
Sept 2021
-
$6.69 M(-40.8%)
June 2021
-
$11.30 M(+41.6%)
Mar 2021
-
$7.98 M(+69.1%)
Dec 2020
$14.75 M(-10.8%)
$4.72 M(+25.8%)
Sept 2020
-
$3.75 M(+28.6%)
June 2020
-
$2.92 M(-13.1%)
Mar 2020
-
$3.36 M(+4.6%)
Dec 2019
$16.53 M(+29.0%)
$3.21 M(-13.7%)
Sept 2019
-
$3.72 M(+1.5%)
June 2019
-
$3.66 M(-38.4%)
Mar 2019
-
$5.94 M(+60.2%)
Dec 2018
$12.81 M(+93.2%)
$3.71 M(+12.6%)
Sept 2018
-
$3.29 M(+17.8%)
June 2018
-
$2.80 M(-7.2%)
Mar 2018
-
$3.01 M(-20.3%)
Dec 2017
$6.63 M(+286.9%)
$3.78 M(+59.2%)
Sept 2017
-
$2.38 M(+1432.3%)
June 2017
-
$155.00 K(-51.7%)
Mar 2017
-
$321.00 K(-101.8%)
Dec 2016
$1.71 M(-95.4%)
-$18.01 M(-419.0%)
Sept 2016
-
$5.65 M(-20.9%)
June 2016
-
$7.14 M(+2.8%)
Mar 2016
-
$6.94 M(-27.0%)
Dec 2015
$36.91 M(-35.1%)
$9.50 M(-16.8%)
Sept 2015
-
$11.43 M(+18.9%)
June 2015
-
$9.61 M(+50.9%)
Mar 2015
-
$6.37 M(-49.4%)
Dec 2014
$56.85 M(-12.8%)
$12.59 M(+4.5%)
Sept 2014
-
$12.04 M(-4.1%)
June 2014
-
$12.56 M(-36.1%)
Mar 2014
-
$19.66 M(+25.7%)
Dec 2013
$65.21 M(+36.6%)
$15.64 M(-23.6%)
Sept 2013
-
$20.48 M(+30.1%)
June 2013
-
$15.74 M(+17.8%)
Mar 2013
-
$13.36 M(-24.5%)
Dec 2012
$47.74 M(+71.8%)
$17.69 M(+19.0%)
Sept 2012
-
$14.86 M(+77.5%)
June 2012
-
$8.37 M(+22.8%)
Mar 2012
-
$6.82 M(-25.9%)
Dec 2011
$27.78 M(+14.2%)
$9.21 M(+74.7%)
Sept 2011
-
$5.27 M(-23.4%)
June 2011
-
$6.88 M(+7.1%)
Mar 2011
-
$6.42 M(+51.2%)
Dec 2010
$24.32 M(+0.6%)
$4.25 M(-45.5%)
Sept 2010
-
$7.79 M(+71.1%)
June 2010
-
$4.55 M(-41.1%)
Mar 2010
-
$7.73 M(-49.1%)
DateAnnualQuarterly
Dec 2009
$24.17 M(+117.5%)
$15.20 M(+533.8%)
Sept 2009
-
$2.40 M(-47.8%)
June 2009
-
$4.59 M(+85.4%)
Mar 2009
-
$2.48 M(-52.8%)
Dec 2008
$11.11 M(-68.6%)
$5.25 M(+97.1%)
Sept 2008
-
$2.66 M(-33.3%)
June 2008
-
$3.99 M(-8.6%)
Mar 2008
-
$4.37 M(-29.4%)
Dec 2007
$35.37 M(-27.3%)
$6.19 M(-40.6%)
Sept 2007
-
$10.43 M(+6.2%)
June 2007
-
$9.82 M(+10.2%)
Mar 2007
-
$8.91 M(-34.4%)
Dec 2006
$48.68 M(+61.9%)
$13.60 M(+12.7%)
Sept 2006
-
$12.07 M(-8.1%)
June 2006
-
$13.14 M(+33.0%)
Mar 2006
-
$9.88 M(-17.6%)
Dec 2005
$30.06 M(+81.4%)
$11.99 M(+32.6%)
Sept 2005
-
$9.04 M(+117.1%)
June 2005
-
$4.16 M(-14.4%)
Mar 2005
-
$4.87 M(-10.7%)
Dec 2004
$16.58 M(+55.4%)
$5.45 M(+47.7%)
Sept 2004
-
$3.69 M(-3.3%)
June 2004
-
$3.82 M(+5.6%)
Mar 2004
-
$3.61 M(+36.5%)
Dec 2003
$10.66 M(-12.6%)
$2.65 M(+4.2%)
Sept 2003
-
$2.54 M(-18.5%)
June 2003
-
$3.12 M(+32.1%)
Mar 2003
-
$2.36 M(-8.7%)
Dec 2002
$12.20 M(+43.0%)
$2.59 M(-23.4%)
Sept 2002
-
$3.37 M(-8.7%)
June 2002
-
$3.69 M(+45.1%)
Mar 2002
-
$2.55 M(+13.7%)
Dec 2001
$8.53 M(+11.7%)
$2.24 M(-10.0%)
Sept 2001
-
$2.49 M(+28.2%)
June 2001
-
$1.94 M(+4.1%)
Mar 2001
-
$1.86 M(+5602.8%)
Dec 2000
$7.64 M(-39.8%)
$32.70 K(-98.7%)
Sept 2000
-
$2.49 M(-1.5%)
June 2000
-
$2.53 M(-2.3%)
Mar 2000
-
$2.59 M(+12.6%)
Dec 1999
$12.69 M(-28.8%)
$2.30 M(-30.2%)
Sept 1999
-
$3.29 M(-15.6%)
June 1999
-
$3.90 M(+14.7%)
Mar 1999
-
$3.40 M(+9.2%)
Dec 1998
$17.81 M(-8.2%)
$3.11 M(-39.0%)
Sept 1998
-
$5.10 M(+21.4%)
June 1998
-
$4.20 M(-23.6%)
Mar 1998
-
$5.50 M(+19.6%)
Dec 1997
$19.40 M(+25.2%)
$4.60 M(-27.0%)
Sept 1997
-
$6.30 M(+37.0%)
June 1997
-
$4.60 M(+17.9%)
Mar 1997
-
$3.90 M(+25.8%)
Dec 1996
$15.50 M(+58.2%)
$3.10 M(-11.4%)
Sept 1996
-
$3.50 M(-2.8%)
June 1996
-
$3.60 M(-30.8%)
Mar 1996
-
$5.20 M(+44.4%)
Dec 1995
$9.80 M(+157.9%)
$3.60 M(+71.4%)
Sept 1995
-
$2.10 M
Dec 1994
$3.80 M
-

FAQ

  • What is Achieve Life Sciences annual total operating expenses?
  • What is the all time high annual operating expenses for Achieve Life Sciences?
  • What is Achieve Life Sciences annual operating expenses year-on-year change?
  • What is Achieve Life Sciences quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Achieve Life Sciences?
  • What is Achieve Life Sciences quarterly operating expenses year-on-year change?

What is Achieve Life Sciences annual total operating expenses?

The current annual operating expenses of ACHV is $27.25 M

What is the all time high annual operating expenses for Achieve Life Sciences?

Achieve Life Sciences all-time high annual total operating expenses is $65.21 M

What is Achieve Life Sciences annual operating expenses year-on-year change?

Over the past year, ACHV annual total operating expenses has changed by -$13.55 M (-33.21%)

What is Achieve Life Sciences quarterly total operating expenses?

The current quarterly operating expenses of ACHV is $12.47 M

What is the all time high quarterly operating expenses for Achieve Life Sciences?

Achieve Life Sciences all-time high quarterly total operating expenses is $20.48 M

What is Achieve Life Sciences quarterly operating expenses year-on-year change?

Over the past year, ACHV quarterly total operating expenses has changed by +$5.89 M (+89.68%)